Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Berve PO, Orlob S(2025) Intra-Arrest Ventilation: We Can Only Improve What We Measure - But What Are Our Devices Really Calculating? Resuscitation, 110914(in press) DOI 10.1016/j.resuscitation.2025.110914, PubMed 41349631
Mori Y, Kopylov U, Sinonquel P, Ebigbo A, Dekker E, De Groof AJ, Ahmad OF, Kader R, Saftoiu A, Schoon E, Mascagni P, Bhandari P, Hann A, Antonelli G, Iacucci M, Pech O, Dray X, Spadaccini M, Campion JR, Hassan C, Messmann H, Bisschops R, Fuccio L, Facciorusso A, Tham T(2025) Correction: Curriculum for safe and effective use of artificial intelligence in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement Endoscopy(in press) DOI 10.1055/a-2765-1088, PubMed 41349574
Wang Y, Van Nieuwenhuysen E, Revheim ME, Deroose CM, Eriksson AGZ, Eyjolfsdottir B, Van Gorp T, Baert T, Aksnes AK, Myren K, Vergote I, Bruland ØS(2025) First experience with intraperitoneal 224Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer Gynecol Oncol, 204, 158-164(in press) DOI 10.1016/j.ygyno.2025.11.018, PubMed 41349345